Skip to main content
. 2020 Nov 6;35(7):1949–1963. doi: 10.1038/s41375-020-01075-3

Fig. 4. Bcor−/−Dnmt3a−/− mice develop thrombocytopenia at leukemic phase.

Fig. 4

A Changes in WBC counts (left) and MCV (right) of Bcor−/−Dnmt3a−/−, Bcor−/−, Dnmt3a−/−and WT control during six months. B Changes in platelets number (left) and Platelets Ratio between 3 and 6 months (right) of Bcor−/−Dnmt3a−/−, Bcor−/−, Dnmt3a−/−, and WT control during 6 months. *p < 0.05, **p < 0.01; ***p < 0.001 unpaired t-test with Welch’s correction.